表紙
市場調查報告書
商品編碼
1070335

敗血症診斷的全球市場:各化驗,各原因,各產品,各實驗室,各場所,附執行顧問指南,敗血症的市場分析與預測(2022年∼2026年)

SEPSIS DIAGNOSTICS. Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides and Sepsis Market Analysis and Forecasts 2022 - 2026

出版日期: | 出版商: Howe Sound Research | 英文 422 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球敗血症診斷市場相關調查,市場概要,以及各化驗、原因、產品、實驗室、場所的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 敗血症診斷概要
  • 市場定義
  • 調查手法
  • 醫療保健,IVD產業,及COVID-19大流行

第3章 敗血症-目前科學

  • 敗血症是什麼
    • 內臟器官損傷
    • 新生兒敗血症
    • 預後
  • 診斷
    • 感染鑑定
    • 生物標記
    • 鑑別診斷
    • 細胞激素風暴-診斷的必要性
  • 敗血症的原因
    • 敗血症的進展
    • 細胞激素風暴-COVID以及其他狀況
  • 盛行率
    • COVID對敗血症的盛行率的影響

第4章 產業概要

  • 動態市場上進入組織
    • 學術研究所
    • 診斷試驗開發業者
    • 醫藥品/試劑供應商
    • 獨立型實驗室
    • 公立國立/地區研究所
    • 院內檢驗室
    • 診療部門檢驗室
    • 審核機關
    • 認證機關

第5章 市場趨勢

  • 成長促進因素
  • 成長阻礙因素
  • 診斷技術的開發

第6章 敗血症的診斷-最近的發展

第7章 主要企業的簡介

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd.
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Biocartis
  • bioM?rieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V./Curetis GmbH
  • Cytovale
  • DNAe
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • LightDeck Diagnostics
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc.

第8章 全球敗血症診斷市場概要

  • 敗血症診斷-全球市場概要,各國
  • 全球敗血症診斷市場概要,各化驗
  • 全球敗血症診斷市場概要,各原因
  • 全球敗血症診斷市場概要,各產品
  • 全球敗血症診斷市場概要,各實驗室
  • 全球敗血症診斷市場概要,各場所

第9章 敗血症診斷市場-各化驗

  • 敗血症診斷-微生物學
  • 敗血症診斷-PCR
  • 敗血症診斷-免疫測量
  • 敗血症診斷-感染疾病及其他
  • 敗血症診斷-生物標記MDx
  • 敗血症診斷-生物標記及其他

第10章 全球敗血症診斷市場-各原因

  • 敗血症診斷-腸胃
  • 敗血症診斷-呼吸系統COVID-19
  • 敗血症診斷-呼吸系統及其他
  • 敗血症診斷-新生兒
  • 敗血症診斷-其他原因

第11章 全球敗血症診斷市場-各產品

  • 敗血症診斷-設備
  • 敗血症診斷-消耗品
  • 敗血症診斷-軟體和服務

第12章 全球敗血症診斷市場-各實驗室

  • 敗血症診斷-實驗室內
  • 敗血症診斷-照護現場

第13章 全球敗血症診斷市場-各場所

  • 敗血症診斷-醫院
  • 敗血症診斷-其他

第14章 附錄

目錄

OVERVIEW:

Sepsis is killing over 45 million people a year with no definitive diagnostic in hand. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market, especially deaths related to COVID infections. Understand the different drivers of this huge global diagnostic market and find where the opportunities lie.

Our facts and support = Your success.

The report forecasts the market size out to 2026. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis - COVID & Sepsis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 An Overview of Sepsis Diagnostics
    • 2.1.1 Sepsis the medical emergency
    • 2.1.2 Sepsis Diagnosis and Comorbidity
  • 2.2 Market Definition
    • 2.2.1 Market Size
    • 2.2.2 Currency
    • 2.2.3 Years
    • 2.2.4 Microbiology
    • 2.2.5 PCR
    • 2.2.6 Immunoassay
    • 2.2.7 Other Infectious Disease
    • 2.2.8 Syndromic PoC
    • 2.2.9 Biomarkers Molecular Diagnostics
    • 2.2.10 Biomarkers Other
    • 2.2.11 Limitations
  • 2.3 Methodology
    • 2.3.1 Authors
    • 2.3.2 Sources
  • 2.4 Healthcare, the IVD Industry, and the COVID-19 Pandemic
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Sepsis - Current Science

  • 3.1 What is Sepsis?
    • 3.1.1 Organ Damage
    • 3.1.2 Neonatal sepsis
    • 3.1.3 Prognosis
  • 3.2 Diagnosis
    • 3.2.1 Infection Identification
    • 3.2.2 Biomarkers
    • 3.2.3 Differential diagnosis
    • 3.2.4 The Cytokine Storm - Diagnostic Needs
  • 3.3 Causes of Sepsis
    • 3.3.1 Sepsis Progression
    • 3.3.2 The Cytokine Storm - COVID and Other Situations
  • 3.4 Prevalence
    • 3.4.1 Impact of COVID on Sepsis Prevalence

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Pharmaceutical/Reagent Supplier
    • 4.1.4 Independent Testing Lab
    • 4.1.5 Public National/regional lab
    • 4.1.6 Hospital lab
    • 4.1.7 Physician Lab
    • 4.1.8 Audit Body
    • 4.1.9 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 Increasing Prevalence
    • 5.1.2 Antimicrobial Resistance
    • 5.1.3 Increasing Diagnosis
    • 5.1.4 Multiplex Diagnostics Impacts
    • 5.1.5 The Aging World
    • 5.1.6 COVID Market Impact
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve Shrinks the Market
    • 5.2.2 The Diagnostics Dillemma
    • 5.2.3 Adoption Lag and Cost Control
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Multiplex Opportunity
    • 5.3.2 Shifting Role of Physicians in Diagnosis
    • 5.3.3 Diagnostics Moves Out of the Lab
    • 5.3.4 Biomarkers and Algorithms
    • 5.3.5 Rapid Testing Changing Medical Practice
    • 5.3.6 Genome Role and Big Data
    • 5.3.7 The Next Five Years

6 Sepsis Diagnostics - Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Cytovale Prepping Sepsis Test for FDA Submission
  • 6.3 Great North R & I to Develop POC Sepsis Dx
  • 6.4 Pathogenomix Developing Sepsis Testing Platform
  • 6.5 Gradientech Launches Study of AST System
  • 6.6 Sepsis Test Developers Accelerate Plans
  • 6.7 Immunexpress Receives Clearance for Sepsis Assay
  • 6.8 Prenosis, Roche Partner on Sepsis Detection
  • 6.9 Presymptom Health Developing Test for Sepsis
  • 6.10 Ortho Clinical Diagnostics Interleukin-6 Reagent Pack
  • 6.11 Cytovale to Enter Sepsis Testing Market
  • 6.12 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis
  • 6.13 Personalized Medicine in Sepsis
  • 6.14 Point-of-care Device can Diagnose Sepsis in 30 Minutes
  • 6.15 SpeeDx Developing Respiratory Virus Host-Response Test
  • 6.16 Scanogen Developing Blood Infection Test with Sepsis Application
  • 6.17 Inflammatix Developing New Sepsis Dx
  • 6.18 Immunexpress, Biocartis to Roll Out Sepsis Test
  • 6.19 Sepset Biosciences Using COVID-19 Patient Samples to Validate Sepsis Test
  • 6.20 Immunexpress to Develop Sepsis Test
  • 6.21 DNAe Developing POC Sequencing for Sepsis
  • 6.22 NGS technique offers quick, accurate diagnosis of Sepsis
  • 6.23 Portable device diagnoses sepsis faster
  • 6.24 Ontera and QuantuMDx Collaborate on Sepsis Dx
  • 6.25 Blood Test Accurately Predicts Sepsis Severity
  • 6.26 BARDA/ HHS to support Cytovale rapid test
  • 6.27 Mologic Developing Sepsis Test withMultimarker
  • 6.28 Abionic: Diagnosis of Sepsis in 5 Minutes
  • 6.29 T2 Biosystems Updates Rapid Diagnostic
  • 6.30 Sepsis found to fit into 4 Subtypes
  • 6.31 GenMark Diagnostics Receives Clearance for Blood Panel
  • 6.32 Novacyt, Immunexpress Extend Sepsis Dx Partnership
  • 6.33 New Test Could Diagnose Sepsis Faster
  • 6.34 Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
  • 6.35 Curetis' Unyvero Cartridges Receive Approvals
  • 6.36 Experimental 2.5-minute Sepsis Test Discovered
  • 6.37 Septec Team Working on 15 Minute Sepsis Diagnosis

7 Profiles of Key Companies

  • 7.1 Abbott Diagnostics
  • 7.2 Abionic
  • 7.3 Accel Diagnostics
  • 7.4 Accelerate Diagnostics
  • 7.5 Axis-Shield Diagnostics Ltd.
  • 7.6 Beckman Coulter Diagnostics
  • 7.7 Becton, Dickinson and Company
  • 7.8 Biocartis
  • 7.9 bioMérieux Diagnostics
  • 7.10 Bio-Rad Laboratories, Inc.
  • 7.11 Bruker
  • 7.12 Cube Dx
  • 7.13 Curetis N.V. / Curetis GmbH
  • 7.14 Cytovale
  • 7.15 DNAe
  • 7.16 EKF Diagnostics Holdings
  • 7.17 GeneFluidics
  • 7.18 GenMark Dx
  • 7.19 Grifols
  • 7.20 Immunexpress
  • 7.21 Inflammatix
  • 7.22 LightDeck Diagnostics
  • 7.23 Linear Diagnostics
  • 7.24 Luminex Corp
  • 7.25 Mbio Diagnostics
  • 7.26 Mobidiag
  • 7.27 Nanomix
  • 7.28 Qiagen Gmbh
  • 7.29 Response Biomedical
  • 7.30 Roche Molecular Diagnostics
  • 7.31 SeLux Diagnostics
  • 7.32 Septec
  • 7.33 Siemens Healthineers
  • 7.34 Sphingotec
  • 7.35 T2 Biosystems
  • 7.36 Thermo Fisher Scientific Inc.

8 Sepsis Global Diagnostic Markets Overview

  • 8.1 Sepsis Diagnostics - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Sepsis Diagnostics Markets Overview by Assay
    • 8.2.1 Table - Global Market by Assay
    • 8.2.2 Chart - Global Market by Assay - Segments Growth
    • 8.2.3 Chart - Global Market by Assay - Share by Year
    • 8.2.4 Chart - Global Market by Assay
    • 8.2.5 Chart - Global Market by Assay - Base Year
    • 8.2.6 Chart - Global Market by Assay - Final Year
  • 8.3 Global Sepsis Diagnostics Markets Overview by Cause
    • 8.3.1 Table - Global Market by Cause
    • 8.3.2 Chart - Global Market by Cause - Segments Growth
    • 8.3.3 Chart - Global Market by Cause - Share by Year
    • 8.3.4 Chart - Global Market by Cause
    • 8.3.5 Chart - Global Market by Cause - Base Year
    • 8.3.6 Chart - Global Market by Cause - Final Year
  • 8.4 Global Sepsis Diagnostics Markets Overview by Product
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Share by Year
    • 8.4.4 Chart - Global Market by Product
    • 8.4.5 Chart - Global Market by Product - Base Year
    • 8.4.6 Chart - Global Market by Product - Final Year
  • 8.5 Global Sepsis Diagnostics Markets Overview by Lab
    • 8.5.1 Table - Global Market by Lab
    • 8.5.2 Chart - Global Market by Lab - Segments Growth
    • 8.5.3 Chart - Global Market by Lab - Share by Year
    • 8.5.4 Chart - Global Market by Lab
    • 8.5.5 Chart - Global Market by Lab - Base Year
    • 8.5.6 Chart - Global Market by Lab - Final Year
  • 8.6 Global Sepsis Diagnostics Markets Overview by Place
    • 8.6.1 Table - Global Market by Place
    • 8.6.2 Chart - Global Market by Place - Segments Growth
    • 8.6.3 Chart - Global Market by Place - Share by Year
    • 8.6.4 Chart - Global Market by Place
    • 8.6.5 Chart - Global Market by Place - Base Year
    • 8.6.6 Chart - Global Market by Place - Final Year

9 Sepsis Diagnostic Market - by Assay

  • 9.1 Sepsis Diagnostic - Microbiology
    • 9.1.1 Table Sepsis Diagnostic Microbiology - by Country
    • 9.1.2 Chart - Sepsis Diagnostic Microbiology Growth
  • 9.2 Sepsis Diagnostic - PCR
    • 9.2.1 Table Sepsis Diagnostic PCR - by Country
    • 9.2.2 Chart - Sepsis Diagnostic PCR Growth
  • 9.3 Sepsis Diagnostic - Immunoassay
    • 9.3.1 Table Sepsis Diagnostic Immunoassay - by Country
    • 9.3.2 Chart - Sepsis Diagnostic - Immunoassay Growth
  • 9.4 Sepsis Diagnostic - Infectious Disease Other
    • 9.4.1 Table Sepsis Diagnostic Infectious Disease Other - by Country
    • 9.4.2 Chart - Sepsis Diagnostic - Infectious Disease Other Growth
  • 9.5 Sepsis Diagnostic - Biomarker MDx
    • 9.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
    • 9.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
  • 9.6 Sepsis Diagnostic - Biomarker Other
    • 9.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
    • 9.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

10 Global Sepsis Diagnostics Markets - By Cause

  • 10.1 Sepsis Diagnostic - GastroIntestinal
    • 10.1.1 Table Sepsis Diagnostic GastroIntestinal - by Country
    • 10.1.2 Chart - Sepsis Diagnostic GastroIntestinal Growth
  • 10.2 Sepsis Diagnostic - Respiratory COVID-19
    • 10.2.1 Table Sepsis Diagnostic Respiratory COVID-19- by Country
    • 10.2.2 Chart - Sepsis Diagnostic Respiratory COVID-19
  • 10.3 Sepsis Diagnostic - Respiratory Other
    • 10.3.1 Table Sepsis Diagnostic Respiratory Other - by Country
    • 10.3.2 Chart - Sepsis Diagnostic - Respiratory Other Growth
  • 10.4 Sepsis Diagnostic - Neonatal
    • 10.4.1 Table Sepsis Diagnostic Neonatal - by Country
    • 10.4.2 Chart - Sepsis Diagnostic - Neonatal Growth
  • 10.5 Sepsis Diagnostic - Other Cause
    • 10.5.1 Table Sepsis Diagnostic Other Cause - by Country
    • 10.5.2 Chart - Sepsis Diagnostic - Other Cause Growth

11 Global Sepsis Diagnostics Markets - By Product

  • 11.1 Sepsis Diagnostic - Instrumentation
    • 11.1.1 Table Sepsis Diagnostic Instrumentation - by Country
    • 11.1.2 Chart - Sepsis Diagnostic Instrumentation Growth
  • 11.2 Sepsis Diagnostic - Consumables
    • 11.2.1 Table Sepsis Diagnostic Consumables - by Country
    • 11.2.2 Chart - Sepsis Diagnostic Consumables
  • 11.3 Sepsis Diagnostic - Software & Service
    • 11.3.1 Table Sepsis Diagnostic Software & Service - by Country
    • 11.3.2 Chart - Sepsis Diagnostic - Software & Service Growth

12 Global Sepsis Diagnostics Markets - By Lab

  • 12.1 Sepsis Diagnostic - In Lab
    • 12.1.1 Table Sepsis Diagnostic In Lab - by Country
    • 12.1.2 Chart - Sepsis Diagnostic In Lab Growth
  • 12.2 Sepsis Diagnostic - Point of Care
    • 12.2.1 Table Sepsis Diagnostic Point of Care - by Country
    • 12.2.2 Chart - Sepsis Diagnostic Point of Care

13 Global Sepsis Diagnostics Markets - By Place

  • 13.1 Sepsis Diagnostic - Hospital
    • 13.1.1 Table Sepsis Diagnostic Hospital - by Country
    • 13.1.2 Chart - Sepsis Diagnostic Hospital Growth
  • 13.2 Sepsis Diagnostic - Other Place
    • 13.2.1 Table Sepsis Diagnostic Other Place - by Country
    • 13.2.2 Chart - Sepsis Diagnostic Other Place

14 Appendices

  • 14.1 United States Medicare System: 2022 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1 sepsis biomarkers - Established and potential
  • Table 2 Market Players by Type
  • Table 3 Five Factors Driving Growth
  • Table 4 Three Factors Limiting Growth
  • Table 5 - Global Sepsis Diagnostics Market by Country/Region
  • Table 6 Global Market by Assay
  • Table 7 Global Market by Cause
  • Table 8 Global Market by Product
  • Table 9 Global Market by Lab
  • Table 10 Global Market by Place
  • Table 11 Sepsis Diagnostic Microbiology by Country
  • Table 12 Sepsis Diagnostic PCR by Country
  • Table 13 Sepsis Diagnostic Immunoassay by Country
  • Table 14 Sepsis Diagnostic Infectious Disease Other by Country
  • Table 15 Sepsis Diagnostic Biomarker MDx by Country
  • Table 16 Sepsis Diagnostic Biomarker Other by Country
  • Table 17 Sepsis Diagnostic GastroIntestinal by Country
  • Table 18 Sepsis Diagnostic Respiratory COVID-19 by Country
  • Table 19 Sepsis Diagnostic Respiratory Other by Country
  • Table 20 Sepsis Diagnostic Neonatal by Country
  • Table 21 Sepsis Diagnostic Other Cause by Country
  • Table 22 Sepsis Diagnostic Instrumentation by Country
  • Table 23 Sepsis Diagnostic Consumables by Country
  • Table 24 Sepsis Diagnostic Software & Service by Country
  • Table 25 Sepsis Diagnostic In Lab by Country
  • Table 26 Sepsis Diagnostic Point of Care by Country
  • Table 27 Sepsis Diagnostic Hospital by Country
  • Table 28 Sepsis Diagnostic Other Place by Country
  • Table 29 2022 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Sepsis Survival graph
  • Figure 2 Percentage of Sepsis Patients with Comorbidity
  • Figure 3 Global Healthcare Spending Map
  • Figure 4 The Lab Test Pie - Wholesale and Retail
  • Figure 5 Sepsis Clinical Progression
  • Figure 6 Deaths From Drug Resistant Infections 2050
  • Figure 7 Aggregate Age of World Population
  • Figure 8 Growth in Health Care Spending Developing World
  • Figure 9 Comparing The New Diagnostics and Traditional Testing
  • Figure 10 Growth rates of Sepsis Diagnostics
  • Figure 11 Global Market Share Chart
  • Figure 12 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 13 Sepsis Diagnostics Market by Assay Base Year
  • Figure 14 Sepsis Diagnostics Market by Assay Final Year
  • Figure 15 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 16 Sepsis Diagnostics Market by Cause Base Year
  • Figure 17 Sepsis Diagnostics Market by Cause Final Year
  • Figure 18 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 19 Sepsis Diagnostics Market by Product Base Year
  • Figure 20 Sepsis Diagnostics Market by Product Final Year
  • Figure 21 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 22 Sepsis Diagnostics Market by Lab Base Year
  • Figure 23 Sepsis Diagnostics Market by Lab Final Year
  • Figure 24 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 25 Sepsis Diagnostics Market by Place Base Year
  • Figure 26 Sepsis Diagnostics Market by Place Final Year
  • Figure 27 Sepsis Diagnostic Microbiology Growth
  • Figure 28 SEPSIS Diagnostics Syndromic POC Panel Growth
  • Figure 29 Sepsis Diagnostic Immunoassay Growth
  • Figure 30 Sepsis Diagnostic Infectious Disease Other Growth
  • Figure 31 Sepsis Diagnostic Biomarker MDx Growth
  • Figure 32 Sepsis Diagnostic Biomarker Other Growth
  • Figure 33 Sepsis Diagnostic GastroIntestinal Growth
  • Figure 34 SEPSIS Diagnostics Respiratory COVID-19
  • Figure 35 Sepsis Diagnostic Respiratory Other Growth
  • Figure 36 Sepsis Diagnostic Neonatal Growth
  • Figure 37 Sepsis Diagnostic Other Cause Growth
  • Figure 38 Sepsis Diagnostic Instrumentation Growth
  • Figure 39 SEPSIS Diagnostics Consumables
  • Figure 40 Sepsis Diagnostic Software & Service Growth
  • Figure 41 Sepsis Diagnostic In Lab Growth
  • Figure 42 SEPSIS Diagnostics Point of Care
  • Figure 43 Sepsis Diagnostic GastroIntestinal Growth
  • Figure 44 SEPSIS Diagnostics Other Place